Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
M33 Growth I L.P.
Director at Starling Oncology. Filing since 20 May 2025.
CIK 0001718621
Company
Date
Role
Action
Shares
Amount
Of holding
STLN
Starling Oncology, Inc.
4 Sep 2025
Director
Sold at will
6,018,168
$18.60M
43.1%
STLN
Starling Oncology, Inc.
4 Sep 2025
Director
Sold at will
681,832
$2.11M
53.6%
STLN
Starling Oncology, Inc.
5 Jun 2025
Director
Sold at will
673,676
$2.05M
4.6%
STLN
Starling Oncology, Inc.
5 Jun 2025
Director
Sold at will
76,324
$232.79K
5.7%
STLN
Starling Oncology, Inc.
20 May 2025
Director
Sold at will
1,796,468
$4.87M
10.9%
STLN
Starling Oncology, Inc.
20 May 2025
Director
Sold at will
203,532
$552.16K
13.1%
6 decisions on file.
